rs1558064
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_002047.4(GARS1):c.659-43C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.598 in 1,482,540 control chromosomes in the GnomAD database, including 277,389 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.48 ( 21416 hom., cov: 32)
Exomes 𝑓: 0.61 ( 255973 hom. )
Consequence
GARS1
NM_002047.4 intron
NM_002047.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.151
Publications
12 publications found
Genes affected
GARS1 (HGNC:4162): (glycyl-tRNA synthetase 1) This gene encodes glycyl-tRNA synthetase, one of the aminoacyl-tRNA synthetases that charge tRNAs with their cognate amino acids. The encoded enzyme is an (alpha)2 dimer which belongs to the class II family of tRNA synthetases. It has been shown to be a target of autoantibodies in the human autoimmune diseases, polymyositis or dermatomyositis. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2015]
GARS1 Gene-Disease associations (from GenCC):
- Charcot-Marie-Tooth disease type 2DInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
- neuronopathy, distal hereditary motor, type 5AInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Illumina, Laboratory for Molecular Medicine
- spinal muscular atrophy, infantile, James typeInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 7-30603453-C-A is Benign according to our data. Variant chr7-30603453-C-A is described in ClinVar as [Benign]. Clinvar id is 258537.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.642 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GARS1 | ENST00000389266.8 | c.659-43C>A | intron_variant | Intron 5 of 16 | 1 | NM_002047.4 | ENSP00000373918.3 | |||
GARS1 | ENST00000675651.1 | c.659-43C>A | intron_variant | Intron 5 of 16 | ENSP00000502513.1 | |||||
GARS1 | ENST00000675810.1 | c.557-43C>A | intron_variant | Intron 4 of 15 | ENSP00000502743.1 | |||||
GARS1 | ENST00000675693.1 | c.491-43C>A | intron_variant | Intron 6 of 17 | ENSP00000502174.1 | |||||
GARS1 | ENST00000675051.1 | c.458-43C>A | intron_variant | Intron 5 of 16 | ENSP00000502296.1 | |||||
GARS1 | ENST00000674815.1 | c.290-43C>A | intron_variant | Intron 5 of 16 | ENSP00000502799.1 | |||||
GARS1 | ENST00000674851.1 | c.290-43C>A | intron_variant | Intron 6 of 17 | ENSP00000502451.1 | |||||
GARS1 | ENST00000444666.6 | n.659-43C>A | intron_variant | Intron 5 of 17 | 3 | ENSP00000415447.2 | ||||
GARS1 | ENST00000674616.1 | n.*373-43C>A | intron_variant | Intron 6 of 17 | ENSP00000502408.1 | |||||
GARS1 | ENST00000674643.1 | n.659-43C>A | intron_variant | Intron 5 of 16 | ENSP00000501636.1 | |||||
GARS1 | ENST00000674737.1 | n.659-43C>A | intron_variant | Intron 5 of 17 | ENSP00000502464.1 | |||||
GARS1 | ENST00000674807.1 | n.659-43C>A | intron_variant | Intron 5 of 15 | ENSP00000502814.1 | |||||
GARS1 | ENST00000675529.1 | n.*529-43C>A | intron_variant | Intron 6 of 17 | ENSP00000501655.1 | |||||
GARS1 | ENST00000675859.1 | n.659-43C>A | intron_variant | Intron 5 of 14 | ENSP00000502033.1 | |||||
GARS1 | ENST00000676088.1 | n.*529-43C>A | intron_variant | Intron 6 of 18 | ENSP00000501884.1 | |||||
GARS1 | ENST00000676140.1 | n.659-43C>A | intron_variant | Intron 5 of 16 | ENSP00000502571.1 | |||||
GARS1 | ENST00000676164.1 | n.*110-43C>A | intron_variant | Intron 5 of 16 | ENSP00000501986.1 | |||||
GARS1 | ENST00000676210.1 | n.659-43C>A | intron_variant | Intron 5 of 17 | ENSP00000502373.1 | |||||
GARS1 | ENST00000676259.1 | n.*91-43C>A | intron_variant | Intron 5 of 16 | ENSP00000501980.1 | |||||
GARS1 | ENST00000676403.1 | n.659-43C>A | intron_variant | Intron 5 of 15 | ENSP00000502681.1 |
Frequencies
GnomAD3 genomes AF: 0.483 AC: 73395AN: 151924Hom.: 21419 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
73395
AN:
151924
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.559 AC: 138079AN: 246982 AF XY: 0.561 show subpopulations
GnomAD2 exomes
AF:
AC:
138079
AN:
246982
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.611 AC: 812985AN: 1330496Hom.: 255973 Cov.: 20 AF XY: 0.606 AC XY: 405808AN XY: 669240 show subpopulations
GnomAD4 exome
AF:
AC:
812985
AN:
1330496
Hom.:
Cov.:
20
AF XY:
AC XY:
405808
AN XY:
669240
show subpopulations
African (AFR)
AF:
AC:
3671
AN:
30766
American (AMR)
AF:
AC:
24482
AN:
44374
Ashkenazi Jewish (ASJ)
AF:
AC:
16949
AN:
25350
East Asian (EAS)
AF:
AC:
17605
AN:
39050
South Asian (SAS)
AF:
AC:
35202
AN:
83482
European-Finnish (FIN)
AF:
AC:
33822
AN:
53048
Middle Eastern (MID)
AF:
AC:
2413
AN:
4336
European-Non Finnish (NFE)
AF:
AC:
646487
AN:
994172
Other (OTH)
AF:
AC:
32354
AN:
55918
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
15788
31576
47365
63153
78941
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.483 AC: 73392AN: 152044Hom.: 21416 Cov.: 32 AF XY: 0.481 AC XY: 35713AN XY: 74292 show subpopulations
GnomAD4 genome
AF:
AC:
73392
AN:
152044
Hom.:
Cov.:
32
AF XY:
AC XY:
35713
AN XY:
74292
show subpopulations
African (AFR)
AF:
AC:
5837
AN:
41504
American (AMR)
AF:
AC:
8148
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
AC:
2369
AN:
3470
East Asian (EAS)
AF:
AC:
2457
AN:
5160
South Asian (SAS)
AF:
AC:
2028
AN:
4820
European-Finnish (FIN)
AF:
AC:
6797
AN:
10562
Middle Eastern (MID)
AF:
AC:
163
AN:
294
European-Non Finnish (NFE)
AF:
AC:
43962
AN:
67942
Other (OTH)
AF:
AC:
1081
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1567
3133
4700
6266
7833
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Spinal muscular atrophy, infantile, James type Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
Jun 26, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Charcot-Marie-Tooth disease type 2D Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Neuronopathy, distal hereditary motor, type 5A Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.